Jardiance (2020-09-14)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Jardiance
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 958266 | - Recalling Firm
- Boehringer Ingelheim (Canada) Ltd
- 5180 South Service Road
- Burlington
- L7L 5H4
- Ontario
- CANADA
- Marketing Authorization Holder
- Boehringer Ingelheim (Canada) Ltd
- 5180 South Service Road
- Burlington
- L7L 5H4
- Ontario
- CANADA
| Jardiance | DIN 02443945 | Tablet | Empagliflozin 25 MG |
The affected lot is out of specification (OOS) for Uniformity of Dosage Units.